Clolar and haemoglobin decreased Patient Reports February 13, 2012

Clolar Side Effects Report #4961842-7
Clolar side effect was reported by a Physician from UNITED STATES on Mar 17, 2006. Female patient, 69 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Clolar. After drug was administered, patient experienced the following side effects: autoimmune thrombocytopenia, bone marrow failure, disseminated intravascular coagulation, epistaxis, haemoglobin decreased, palmar-plantar erythrodysaesthesia syndrome, rash , thrombotic thrombocytopenic purpura. Clolar dosage: unknown. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6083359-1
Clolar side effect was reported by a Physician from UNITED STATES on Feb 06, 2009. Female patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haematocrit decreased, haemoglobin decreased, nausea , neutropenia, neutropenic infection, red blood cell count decreased, thrombocytopenia. Clolar dosage: 19 MG, QDX5; INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO, PRILOSEC. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6086994-X
Clolar side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Female patient, 73 years of age, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: bronchial wall thickening, bronchitis , cardiomegaly, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, hyponatraemia, nausea . Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6099444-4
Clolar side effect was reported by a Physician from UNITED STATES on Feb 18, 2009. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: blood sodium decreased, bronchial wall thickening, bronchitis , cardiomegaly, dehydration, haematocrit decreased, haemoglobin decreased, nausea , neutropenia. Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO, PRILOSEC. Patient was hospitalized. Patient recovered.


Clolar Side Effects Report #6110635-6
Clolar side effect was reported by a Physician from UNITED STATES on Feb 26, 2009. Female patient, 73 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Clolar. After drug was administered, patient experienced the following side effects: bronchitis , cardiomegaly, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, nausea , neutropenic infection, pneumonia . Clolar dosage: 19 MG, QDX5, INTRAVENOUS. During the same period patient was treated with ATENOLOL, CARISOPRODOL, DIOVAN, LEXAPRO, LORAZEPAM, NIFEDIPINE, PREMPRO. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6066252-X
Clolar side effect was reported by a Physician from UNITED STATES on Jan 23, 2009. Female patient, child 11 years of age, weighting 98.77 lb, was diagnosed with b-cell type acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: constipation , depression , haemoglobin decreased, hypokalaemia, insomnia, leukopenia, lymphopenia, nausea , neutropenia. Clolar dosage: 27.2 MG, QDX3, INTRAVENOUS, 27.2 MG, QDX3, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONDANSETRON, ALLOPURINOL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5981495-9
Clolar side effect was reported by a Physician from UNITED STATES on Nov 18, 2008. Male patient, child 9 years of age, weighting 55.56 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: abdominal pain , disease recurrence, haemoglobin decreased, headache , leukopenia, lymphopenia, neutropenia, pain in extremity. Clolar dosage: 19.8 MG, QDX3, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ONDANSETRON, ACETAMINOPHEN, ALLOPURINOL, DIPHENHYDRAMINE, HYDROCORTISONE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6125111-4
Clolar side effect was reported by a Physician from UNITED STATES on Mar 09, 2009. Male patient, child 9 years of age, weighting 55.56 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: abdominal pain , bone marrow failure, eye discharge, haemoglobin decreased, headache , leukopenia, lymphopenia, neutropenia. Clolar dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5582817-3
Clolar side effect was reported by a Physician from UNITED KINGDOM on Dec 18, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: abdominal distension, cardiac failure congestive, haemoglobin decreased, headache , hypokalaemia, left ventricular hypertrophy, lethargy, platelet count decreased, renal impairment. Clolar dosage: 35 MG, QD, INTRAVENOUS. During the same period patient was treated with FLUCLOXACILLIN, AMLODIPINE, LEVOTHYROXINE, BISOPROLOL FUMARATE, TRAMADOL, SIMVASTATIN, CYCLIZINE. Patient was hospitalized. Patient recovered.


Clolar Side Effects Report #6132663-7
Clolar side effect was reported by a Physician from UNITED STATES on Mar 17, 2009. Male patient, 42 years of age, weighting 286.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: adrenal insufficiency, blood pressure decreased, bone marrow transplant , dehydration, dizziness , haematocrit decreased, haemoglobin decreased, red blood cell count decreased, white blood cell count decreased. Clolar dosage: 85 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, ACTIGALL, ACYCLOVIR, ABILIFY, WELLBUTRIN, CLOBETASOL, FLUCONAZOLE, KEPPRA. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5894487-5
Clolar side effect was reported by a Physician from UNITED STATES on Sept 16, 2008. Male patient, child 10 years of age, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cardiac failure, coagulopathy, contusion, haemodialysis, haemoglobin decreased, hypotension, international normalised ratio increased, optic nerve sheath haemorrhage. Clolar dosage: unknown. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5583909-5
Clolar side effect was reported by a Physician from UNITED STATES on Dec 28, 2007. Male patient, 55 years of age, weighting 162.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia, haemoglobin decreased, pericardial effusion, platelet count decreased, renal failure, staphylococcal abscess, staphylococcal bacteraemia, tongue abscess. Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #4591593-2
Clolar side effect was reported by a Health Professional from on Feb 08, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , body temperature increased, bradycardia, haemoglobin decreased, hypertension, neutropenia, tachycardia, ventricular dysfunction, white blood cell count decreased. Clolar dosage: 112 MG QD IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLAGYL. Patient recovered.

Clolar Side Effects Report #4623641-5
Clolar side effect was reported by a Physician from on Mar 15, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood urea increased, body temperature increased, bradycardia, haemoglobin decreased, hypertension, neutropenia, tachycardia, ventricular dysfunction. Clolar dosage: 112 MG QD; IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLAGYL. Patient recovered.


Clolar Side Effects Report #4626406-3
Clolar side effect was reported by a Physician from on Mar 15, 2005. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood urea increased, body temperature increased, bradycardia, haemoglobin decreased, hypertension, neutropenia, tachycardia, ventricular dysfunction. Clolar dosage: 112 MG QD IV. During the same period patient was treated with VANCOMYCIN, CEFTAZIDIME, FLUCONAZOLE, PENTAMIDINE, FLAGYL. Patient recovered.